Characterizing the Use of Ofatumumab in a Real World Setting

Clinical trial NCT05090033 · COMPLETED

Trial details

NCT number: NCT05090033
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2022-12-08
Primary completion: 2026-02-06
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.